In our research, the distribution of PIK3CA H1047R mutation suggested this mutation might be related to good prognosis in oligo-metastatic disease, whether in oligo-metastasis and poly-metastasis groups, or in oligo-metastasis with longer oligo-R and oligo-metastasis with shorter oligo-R. Here, PIK3CA is linked to metastatic neoplasm.